Cambrex Corporation announced the expansion of their stability storage business, First Quarter Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. First Quarter Scientific will open a new 20,000-square-foot cGMP facility in Belgium and add an additional 10,000 square feet at their existing facility in Waterford, Ireland. The expansions will be completed in the first half of 2023.

First Quarter Scientific's new temperature-controlled and monitored storage facility in Belgium will be located in the easily accessible Liege region, approximately 50 miles from Brussels. The facility will provide 35,000 temperature-controlled storage spaces for all key ICH climatic zones, supporting long-term, intermediate and accelerated stability trials, including 2 – 8°C and 25°C /60% RH and 40°C /75%RH. Cambrex continues to expand its capabilities and capacity across its North American and European network to meet the growing demand for outsourced drug development and manufacturing services.